Skip to main content

Preclinical Testing

  • Living reference work entry
  • First Online:
Encyclopedia of Cancer
  • 29 Accesses

Synonyms

Preclinical drug safety evaluation; Preclinical safety testing; Toxicity testing

Definition

The process of testing potential new therapies in animal and cell-based test systems prior to their study in patients in order to assure their potential safety and efficacy.

Characteristics

It was recognized many years ago that potential medicines were often “poisons” so that some form of screening in animal models was required before new drugs could be tried in patients. For all types of medicines, it has been generally agreed that these tests should take the form of both pharmacological and toxicological studies in animals to avoid patients being exposed to drugs that are excessively toxic or without evidence of potential efficacy. Added impetus has come from the Nuremberg Code that was formulated after the trials of the Nazi doctors convicted for the conduct of horrific medical experiments on prisoners. While this code deals primarily with the consent of volunteers and patients, one...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Greaves P, Williams A, Eve M (1997) First dose of potential medicines to humans: how animals help. Nat Rev Drug Discov 3:226–236

    Article  Google Scholar 

  • Schuster E (1997) Fifty years later: the significance of the Nuremberg Code. N Engl J Med 337:1436–1440

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter Greaves .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Greaves, P. (2015). Preclinical Testing. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27841-9_4718-2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27841-9_4718-2

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-27841-9

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics